Skip to content

Evaluation of curative effect and safety of Qinji Liangxue mixture on hemorrhagic internal hemorrhoids of excess heat type based on ultrasonic elastography

Evaluation of curative effect and safety of Qinji Liangxue mixture on hemorrhagic internal hemorrhoids of excess heat type based on ultrasonic elastography

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037160
Enrollment
Unknown
Registered
2020-08-27
Start date
2021-05-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Internal hemorrhoids

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with grade I and II internal hemorrhoids who meet the above diagnostic criteria, and the bleeding symptoms do not exceed 7 days. 2. Those who meet the above diagnostic criteria of TCM syndromes, such as heat stasis syndrome or dampness heat stagnation syndrome. 3. The age is between 18 and 75 years old. 4. The hemorrhoid mucosa congestion, erosion or bleeding point can be seen by anoscopy. 5. Those who voluntarily join the experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with anal fissure, anal fistula, inflammatory bowel disease, blood disease, diabetes, colorectal cancer and other diseases and mental diseases. 2. Pregnant or lactating women. 3. Those who have used the related drugs (including oral drugs and local drugs) for the treatment of internal hemorrhoid bleeding in the past week. 4. Taking anticoagulant drugs, antiplatelet aggregation drugs, hormones, non steroidal analgesics and other drugs that affect the anticoagulant function. 5. Abnormal blood and urine routine, Pt, APTT, AST, alt, AKP, TBIL, bun, SCR, ECG.

Design outcomes

Primary

MeasureTime frame
Disappearance rate of hematochezia after 7 days of treatment;Remission time of hematochezia;Stop time of hematochezia;Evaluation of transrectal ultrasound elastography;

Secondary

MeasureTime frame
Defecation score;

Countries

China

Contacts

Public ContactHu Jie

Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

13774215713@163.com+86 13774215713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026